Regulation and drug development:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Washington, DC
American Enterprise Inst. for Public Policy Research
1975
|
| Schriftenreihe: | Evaluative studies.
21. |
| Schlagworte: | |
| Beschreibung: | 181 S. graph. Darst. |
| ISBN: | 0844731676 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV005764099 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 921030s1975 d||| |||| 00||| eng d | ||
| 020 | |a 0844731676 |9 0-8447-3167-6 | ||
| 035 | |a (OCoLC)1682059 | ||
| 035 | |a (DE-599)BVBBV005764099 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 |a DE-355 |a DE-83 | ||
| 050 | 0 | |a RS122 | |
| 082 | 0 | |a 615/.1/072073 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 100 | 1 | |a Wardell, William M. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Regulation and drug development |c William M. Wardell ; Louis Lasagna* |
| 264 | 1 | |a Washington, DC |b American Enterprise Inst. for Public Policy Research |c 1975 | |
| 300 | |a 181 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Evaluative studies. |v 21. | |
| 650 | 4 | |a Industrie pharmaceutique - États-Unis | |
| 650 | 4 | |a Médicaments - Droit - États-Unis | |
| 650 | 4 | |a Médicaments - Recherche - États-Unis | |
| 650 | 4 | |a Politique sanitaire - États-Unis | |
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Drug Industry |z United States | |
| 650 | 4 | |a Drug and Narcotic Control |z United States | |
| 650 | 4 | |a Drug development |z United States | |
| 650 | 4 | |a Drugs |x Law and legislation |z United States | |
| 650 | 4 | |a Legislation, Drug |z United States | |
| 650 | 4 | |a Pharmaceutical industry |z United States | |
| 650 | 4 | |a Pharmaceutical policy |z United States | |
| 650 | 4 | |a Research |z United States | |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 689 | 0 | 0 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Lasagna, Louis |e Verfasser |4 aut | |
| 830 | 0 | |a Evaluative studies. |v 21. |w (DE-604)BV002790003 |9 21 | |
| 940 | 1 | |q TUB-nveb | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-003600461 | ||
Datensatz im Suchindex
| _version_ | 1804119947596529664 |
|---|---|
| any_adam_object | |
| author | Wardell, William M. Lasagna, Louis |
| author_facet | Wardell, William M. Lasagna, Louis |
| author_role | aut aut |
| author_sort | Wardell, William M. |
| author_variant | w m w wm wmw l l ll |
| building | Verbundindex |
| bvnumber | BV005764099 |
| callnumber-first | R - Medicine |
| callnumber-label | RS122 |
| callnumber-raw | RS122 |
| callnumber-search | RS122 |
| callnumber-sort | RS 3122 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)1682059 (DE-599)BVBBV005764099 |
| dewey-full | 615/.1/072073 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.1/072073 |
| dewey-search | 615/.1/072073 |
| dewey-sort | 3615 11 572073 |
| dewey-tens | 610 - Medicine and health |
| discipline | Wirtschaftswissenschaften Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01862nam a2200541 cb4500</leader><controlfield tag="001">BV005764099</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">921030s1975 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0844731676</subfield><subfield code="9">0-8447-3167-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1682059</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005764099</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-83</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS122</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.1/072073</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wardell, William M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Regulation and drug development</subfield><subfield code="c">William M. Wardell ; Louis Lasagna*</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">American Enterprise Inst. for Public Policy Research</subfield><subfield code="c">1975</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">181 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Evaluative studies.</subfield><subfield code="v">21.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Droit - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Recherche - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politique sanitaire - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug and Narcotic Control</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lasagna, Louis</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Evaluative studies.</subfield><subfield code="v">21.</subfield><subfield code="w">(DE-604)BV002790003</subfield><subfield code="9">21</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">TUB-nveb</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003600461</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV005764099 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:34:17Z |
| institution | BVB |
| isbn | 0844731676 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003600461 |
| oclc_num | 1682059 |
| open_access_boolean | |
| owner | DE-703 DE-355 DE-BY-UBR DE-83 |
| owner_facet | DE-703 DE-355 DE-BY-UBR DE-83 |
| physical | 181 S. graph. Darst. |
| psigel | TUB-nveb |
| publishDate | 1975 |
| publishDateSearch | 1975 |
| publishDateSort | 1975 |
| publisher | American Enterprise Inst. for Public Policy Research |
| record_format | marc |
| series | Evaluative studies. |
| series2 | Evaluative studies. |
| spelling | Wardell, William M. Verfasser aut Regulation and drug development William M. Wardell ; Louis Lasagna* Washington, DC American Enterprise Inst. for Public Policy Research 1975 181 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Evaluative studies. 21. Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Médicaments - Recherche - États-Unis Politique sanitaire - États-Unis Recht Drug Industry United States Drug and Narcotic Control United States Drug development United States Drugs Law and legislation United States Legislation, Drug United States Pharmaceutical industry United States Pharmaceutical policy United States Research United States Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf USA Arzneimittelmarkt (DE-588)4003131-7 s DE-604 Lasagna, Louis Verfasser aut Evaluative studies. 21. (DE-604)BV002790003 21 |
| spellingShingle | Wardell, William M. Lasagna, Louis Regulation and drug development Evaluative studies. Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Médicaments - Recherche - États-Unis Politique sanitaire - États-Unis Recht Drug Industry United States Drug and Narcotic Control United States Drug development United States Drugs Law and legislation United States Legislation, Drug United States Pharmaceutical industry United States Pharmaceutical policy United States Research United States Arzneimittelmarkt (DE-588)4003131-7 gnd |
| subject_GND | (DE-588)4003131-7 |
| title | Regulation and drug development |
| title_auth | Regulation and drug development |
| title_exact_search | Regulation and drug development |
| title_full | Regulation and drug development William M. Wardell ; Louis Lasagna* |
| title_fullStr | Regulation and drug development William M. Wardell ; Louis Lasagna* |
| title_full_unstemmed | Regulation and drug development William M. Wardell ; Louis Lasagna* |
| title_short | Regulation and drug development |
| title_sort | regulation and drug development |
| topic | Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Médicaments - Recherche - États-Unis Politique sanitaire - États-Unis Recht Drug Industry United States Drug and Narcotic Control United States Drug development United States Drugs Law and legislation United States Legislation, Drug United States Pharmaceutical industry United States Pharmaceutical policy United States Research United States Arzneimittelmarkt (DE-588)4003131-7 gnd |
| topic_facet | Industrie pharmaceutique - États-Unis Médicaments - Droit - États-Unis Médicaments - Recherche - États-Unis Politique sanitaire - États-Unis Recht Drug Industry United States Drug and Narcotic Control United States Drug development United States Drugs Law and legislation United States Legislation, Drug United States Pharmaceutical industry United States Pharmaceutical policy United States Research United States Arzneimittelmarkt USA |
| volume_link | (DE-604)BV002790003 |
| work_keys_str_mv | AT wardellwilliamm regulationanddrugdevelopment AT lasagnalouis regulationanddrugdevelopment |